A clinical evaluation of etomidate for outpatient cystoscopy was embarked upon. Unpremedicated patients were given fentanyl 1 JAg/kg followed by etomidate 0.3 mg/kg. Anaesthesia was maintained with intermittent etomidate in 2-4 mg doses. Patients were interviewed personally later the same day, and by questionnaire three to four weeks later. The trial was discontinued after 20 cases because of an unacceptable incidence of side effects. Venous pain occurred in 68% of patients and 50% had redness, pain or swelling related to the injection site, in some cases lasting up to three weeks after anaesthesia. Skeletal movements occurred in 50% of patients; 30% experienced respiratory upset, one sufficiently severe to necessitate abandoning the technique. Nausea and vomiting occurred in 40% and 25 % had disturbing emergence psychoses.
The study of a new induction agent should include evaluation of the drug without premedication, assessment of its role as a sole agent or perhaps with added analgesia, and comparison with a known satisfactory technique. It should not be a prerequisite that veins in the antecubital fossa have to be used.
The technique currently used by the authors for minor urological and gynaecological procedures consists of intermittent injection of an althesin/fentanyl mixture (maximum fentanyl dose approximately 1.5 JAg/kg).
Following considerable satisfactory experience with this technique, especially in outpatients, it was decided to embark upon a clinical trial using etomidate in a similar manner. Etomidate is a water-soluble carboxylated imidazole derivative unrelated to other induction agents. Various formulations have been tried, largely due to a fairly high incidence of venous pain with the aqueous solution. 1, 2 The solution made available to us contained etomidate 2 mg/ml in 35070 propylene glycol ( Figure 1 ).
Etomidate has been shown to induce hypnosis rapidly, to be short-acting and to have a good quality of recovery with little evidence of cumulation,3 thought to be due to its rapid metabolism by hydrolysis. It has little effect on the cardiovascular and respiratory systems and does not appear to release histamine.
Recognised problems with etomidate are pain on injection and muscle movements which can be severe enough to interfere with the surgery. A 23% incidence of respiratory upset i.e. cough, hiccup and laryngospasm is reported by Holdcroft et al. 2 
METHOD
Informed consent was obtained from patients about to undergo minor urological procedures. None was rejected on grounds of age, but pregnant women were excluded.
There were 20 patients (11 male, nine female) and they were all ASA categories I or 11. No distinction was made between these categories. All patients had medical history, physical examination, blood pressure and pulse rate recorded prior to commencing the procedure.
A 25 ga "Butterfly" needle was inserted into a vein, the back of the hand being the site of first choice. Fentanyl 1 /Jg/kg was injected one minute prior to etomidate 0.3 mg/kg. The details of the anaesthesia are shown in Table 1 . The duration of surgery was from 10 to 40 minutes (mean 18 ± 8). The patient was observed for comment or sign of discomfortif this occurred, the nature and site of discomfort were elicited. If the patient did not indicate discomfort, a neutral comment e.g. "Is that quite comfortable?" was made. Blood pressure and pulse rate were recorded by Dinamap automatic recorder and an ECG monitor was observed throughout.
Subsequent anaesthesia was maintained by injection of 1-2 ml increments of etomidate and one of the authors accompanied each patient to the recovery room to observe waking and alertness. The patients were all seen again later the same day, and a questionnaire was sent to each about three to four weeks following anaesthesia. In this questionnaire, specific questions were asked about the patient's experience of induction, whether any adverse effects had been noted and whether there were any sequelae. Patients were asked to assess the quality of the induction, and to give their overall impression of the anaesthetic.
RESULTS
There was a 100070 response to the questionnaire.
Venous pain at induction occurred in 13 of 19 patients who had injections in the back of the hand although only nine of these remembered it afterwards. One patient had poor hand veins, and received the drug in the antecubital fossa; he had no pain. Postoperative venous sequelae were elicited from 50% of patients with the distribution as shown in Table 2 , and of these, seven had involvement of the hand only but three had involvement of the hand and arm. There was no correlation between pain and postoperative sequelae. Respiratory upset, defined as coughing, hiccupping or laryngospasm, or a combination, occurred in six patients, two at induction only but three persisting through induction and maintenance giving a 30070 incidence.
Skeletal movements occurred in 50070 of patients and were graded as mild (six patients), moderate (two patients) or severe (two patients). The severe movements made surgery impossible in one case, and difficult in the other.
The anaesthetist's assessment of induction and maintenance is shown in Table 3 . A good induction was one where there was an apparently smooth loss of consciousness, albeit in some cases associated with some venous pain. Those rated fair or unsatisfactory had severe pain and/or other associated problems such as coughing or marked skeletal movements. In the recovery period four patients were nauseated, three had nausea and vomiting and one vomited but did not complain of nausea, giving an overall 40070 incidence.
Details of recovery are shown in Table 4 . The mean waking time was 7.6 ± 5.9 minutes. One patient took 25 minutes, which was unusually long. The mean time to alertness, i.e. giving name, address and date of birth, was 10.3 ± 4.2 minutes for 18 cases with two cases being quite prolonged at 40 minutes and 70 minutes. The patient who took 25 minutes to wake, took 70 minutes to achieve alertness. Five of the patients had emergence psychoses. Nine felt they were drowsy and confused postoperatively and four were still drowsy or confused the following day. The patients' assessments of induction and maintenance are shown in Tables 5 and 6. Seven patients (35070) would prefer not to have this agent again. 
DISCUSSION
The apparent advantages of etomidate over other agents suggest its use for short diagnostic day-case procedures -as an alternative agent in patients where cardiovascular stability is of particular importance, and to avoid the allergic phenomena associated with agents such as althesin and propanidid. However, after only a small number of cases, it became apparent that the problem associated with the use of etomidate in this technique could not be overcome and the trial was discontinued, after only 20 of the proposed 50 patients had been studied.
The incidence of pain at induction was unexpectedly high, especially since we were using the formulation with propylene glycol which has been shown to be associated with a much lower incidence of pain than the aqueous solution,4 and the injection was preceded by fentanyl in an effort to minimize the pain. However, it was felt that the use of large veins, especially those of the antecubital fossa, imposed undue restriction on the technique whilst introducing the problems of inadvertent intra-arterial injection and dislodgement of the needle with movement at the elbow.
The number of patients who had pain, redness and swelling related to the injection site was striking at 50070. Five patients had pain and swelling of the hand or arm to such a degree that they were unable to continue their normal activities and requested medical advice. These problems settled only slowly, pain and tenderness being described by three patients three weeks after anaesthesia. These findings are comparable with those of Zacharias et al. 5 who found the propylene glycol formulation gave an incidence of venous sequelae of 55% on the third day and 45% on the fourteenth day. They also noted that the frequency of extended thrombophlebitis was greater with this formulation. This contrasts with the small incidence of sequelae reported earlier'·6 but these studies were using the aqueous solution and the patients were not followed beyond three days.
Muscle movements occurred in half of our patients and in two were so severe as to hamper surgery. Increasing the amount of etomidate given, and thus, presumably, the depth of cortical depression, did not have any effect.
Respiratory upset occurred in 30% of patients, usually cough or hiccup but in one case the technique was abandoned and halothane used to settle the patient to enable surgery to proceed. Holdcroft et al.' reported a 23% incidence of respiratory disturbance, but this was at induction only.
Nausea and vomiting occurred in 40% of patients but was usually short-lived. Two patients required anti-emetic medication -one immediately after anaesthesia and one about two hours later. The incidence of nausea and vomiting postoperatively is apparently higher than that following other agents. Holdcroft et al.' report a 25 % incidence in general surgical patients and Zacharias et al. report a 30% incidence in gynaecological patients compared with a 25% incidence in similar patients following althesin. 7 While the time to achieve alertness was satisfactorily short in most cases, two patients showed prolonged time to alertness and furthermore, nine patients were drowsy or confused later the same day and of these, four remained so the following day. Another disturbing problem encountered was emergence psychosis in 25% of our patients. They were disorientated, confused and irrational. The patients themselves recalled being "hysterical", having hallucinations and being out of control of mental processes. They found it a totally frightening experience, as did our recovery staff and the other patients in the ward. These five were among the seven who would prefer not to have the drug again.
Clearly, etomidate is not a satisfactory agent for use in this manner. The number and severity of side effects was greater than had been anticipated from the literature and the unpredictability of the drug with each patient was quite striking.
A few patients, not included in this study, were given etomidate for bronchoscopy in conjunction with paralysis using suxamethonium, which, of course, abolished a number of the problems associated with the drug. It remains to be seen whether there are perhaps other ways in which the disadvantages of this drug may be minimised. It certainly appears that propylene glycol leaves something to be desired as a solvent. It may be that polyethylene glycol is better, but there is conflicting evidence on the relative merits of these agents, and the one associated with less pain may not necessarily be associated with fewer venous sequelae.
We were forced to conclude that this technique was an unsuitable one for etomidate, but would emphasise that these findings not be taken as reasons for rejecting this drug altogether. According to Savege 8 " ••• learning to use (a new agent) to its best advantage will take time. Different techniques and combinations of drugs may have to be developed. It would be very unfortunate if new anaesthetic agents were rejected before suitable techniques had been developed for their use and their full potential explored".
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